15 March 2017

Paul Scheepers, dept for Health Evidence, was appointed by DG SANTE as risk assessment expert to support the European Commission in the case of serious cross-border chemical health threats.

This task is performed in the context of decision 1082/2013/EU to respond to incidents or alerts of serious cross-border health threats. When a coordinated response at EU level is required, the Commission involve experts to prepare an assessment of the severity of the public health threat, including possible public health measures. These incidents may include both manmade and naturally occurring events. It is also possible that the EU deploys experts in such incidents outside the EU on request of one of the EU member states. This occurred on request of France in the earthquake in Haiti in 2010. Paul Scheepers will contribute to preparing ad hoc rapid risk assessments in collaboration with field officers deployed on location. For this task he was trained in November last year and in March this year he will receive further. He has prior experience as public health advisor hazardous materials (GAGS) for five safety regions in the South of The Netherlands since 2007. In 2012 he contributed to establish a national guidance on human biological monitoring following chemical incidents and published two scientific papers on this subject. He supported the use of biomonitoring in response to a train incident on May 4th 2013 in Wetteren near Ghent in Belgium. This incident resulted in 33 injuries, 1 fatality and exposure of thousands of inhabitants and hundreds of first responders to acrylonitrile. In 2014 he edited a special issue of Toxicology Letters on the application of biomonitoring in response to chemical incidents.

More information: link
 

Related news items


Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano

23 September 2020

Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 707,298 euros to study the cancer cell surface in immunotherapy.

read more

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more